TY - JOUR
T1 - Differential effects of endogenous and synthetic cannabinoids on α7-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes
AU - Oz, Murat
AU - Zhang, Li
AU - Ravindran, Arippa
AU - Morales, Marisela
AU - Lupica, Carl R.
PY - 2004/9
Y1 - 2004/9
N2 - The effects of endogenous and synthetic cannabinoid receptor agonists, including 2-arachidonoylglycerol (2-AG), R-methanandamide, WIN55,212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl) -6H-pyrrolo[3,2,1ij]quinolin-6-one], and CP 55,940 [1α,2β-(R)- 5α]-(-)-5-(1,1-dimethyl)-2-[5-hydroxy-2-(3-hydroxypropyl) cyclohexyl-phenol], and the psychoactive constituent of marijuana, Δ9-tetrahydrocannabinol (Δ9-THC), on the function of homomeric α7-nicotinic acetylcholine (nACh) receptors expressed in Xenopus oocytes was investigated using the two-electrode voltage-clamp technique. The endogenous cannabinoid receptor ligands 2-AG and the metabolically stable analog of anandamide (arachidonylethanolamide), R-methanandamide, reversibly inhibited currents evoked with ACh (100 μM) in a concentration-dependent manner (IC50 values of 168 and 183 nM, respectively). In contrast, the synthetic cannabinoid receptor agonists CP 55,940, WIN55,212-2, and the phytochemical Δ9-THC did not alter α7-nACh receptor function. The inhibition of α7-mediated currents by 2-AG was found to be non-competitive and voltage-independent. Additional experiments using endocannabinoid metabolites suggested that arachidonic acid, but not ethanolamine or glycerol, could also inhibit the α7-nACh receptor function. Whereas the effects of arachidonic acid were also noncompetitive and voltage-independent, its potency was much lower than 2-AG and anandamide. Results of studies with chimeric α7-nACh-5-hydroxytryptamine (5-HT)3 receptors comprised of the amino-terminal domain of the α7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT 3 receptors indicated that the site of interaction of the endocannabinoids with the α7-nAChR was not located on the N-terminal region of the receptor. These data indicate that cannabinoid receptor ligands that are produced in situ potently inhibit α7-nACh receptor function, whereas the synthetic cannabinoid ligands, and Δ9-THC, are without effect, or are relatively ineffective at inhibiting these receptors.
AB - The effects of endogenous and synthetic cannabinoid receptor agonists, including 2-arachidonoylglycerol (2-AG), R-methanandamide, WIN55,212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl) -6H-pyrrolo[3,2,1ij]quinolin-6-one], and CP 55,940 [1α,2β-(R)- 5α]-(-)-5-(1,1-dimethyl)-2-[5-hydroxy-2-(3-hydroxypropyl) cyclohexyl-phenol], and the psychoactive constituent of marijuana, Δ9-tetrahydrocannabinol (Δ9-THC), on the function of homomeric α7-nicotinic acetylcholine (nACh) receptors expressed in Xenopus oocytes was investigated using the two-electrode voltage-clamp technique. The endogenous cannabinoid receptor ligands 2-AG and the metabolically stable analog of anandamide (arachidonylethanolamide), R-methanandamide, reversibly inhibited currents evoked with ACh (100 μM) in a concentration-dependent manner (IC50 values of 168 and 183 nM, respectively). In contrast, the synthetic cannabinoid receptor agonists CP 55,940, WIN55,212-2, and the phytochemical Δ9-THC did not alter α7-nACh receptor function. The inhibition of α7-mediated currents by 2-AG was found to be non-competitive and voltage-independent. Additional experiments using endocannabinoid metabolites suggested that arachidonic acid, but not ethanolamine or glycerol, could also inhibit the α7-nACh receptor function. Whereas the effects of arachidonic acid were also noncompetitive and voltage-independent, its potency was much lower than 2-AG and anandamide. Results of studies with chimeric α7-nACh-5-hydroxytryptamine (5-HT)3 receptors comprised of the amino-terminal domain of the α7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT 3 receptors indicated that the site of interaction of the endocannabinoids with the α7-nAChR was not located on the N-terminal region of the receptor. These data indicate that cannabinoid receptor ligands that are produced in situ potently inhibit α7-nACh receptor function, whereas the synthetic cannabinoid ligands, and Δ9-THC, are without effect, or are relatively ineffective at inhibiting these receptors.
UR - http://www.scopus.com/inward/record.url?scp=4243057253&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4243057253&partnerID=8YFLogxK
U2 - 10.1124/jpet.104.067751
DO - 10.1124/jpet.104.067751
M3 - Article
C2 - 15102930
AN - SCOPUS:4243057253
SN - 0022-3565
VL - 310
SP - 1152
EP - 1160
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -